HK1210136A1 - Ingenol-derived compounds that can be used for treating cancer - Google Patents

Ingenol-derived compounds that can be used for treating cancer

Info

Publication number
HK1210136A1
HK1210136A1 HK15110775.3A HK15110775A HK1210136A1 HK 1210136 A1 HK1210136 A1 HK 1210136A1 HK 15110775 A HK15110775 A HK 15110775A HK 1210136 A1 HK1210136 A1 HK 1210136A1
Authority
HK
Hong Kong
Prior art keywords
ingenol
treating cancer
derived compounds
derived
compounds
Prior art date
Application number
HK15110775.3A
Other languages
English (en)
Chinese (zh)
Inventor
Luiz Francisco Pianowski
Everardo Ferreira Telles
Original Assignee
Amazonia Fitomedicamentos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50626235&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1210136(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amazonia Fitomedicamentos Ltda filed Critical Amazonia Fitomedicamentos Ltda
Publication of HK1210136A1 publication Critical patent/HK1210136A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
HK15110775.3A 2012-11-01 2015-11-02 Ingenol-derived compounds that can be used for treating cancer HK1210136A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR102012028120A BR102012028120B8 (pt) 2012-11-01 2012-11-01 Uso de um ou mais derivados de ingenol, composição farmacêutica e medicamento
PCT/BR2013/000455 WO2014066967A1 (pt) 2012-11-01 2013-10-31 Compostos derivados de ingenol úteis no tratamento de câncer

Publications (1)

Publication Number Publication Date
HK1210136A1 true HK1210136A1 (en) 2016-04-15

Family

ID=50626235

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110775.3A HK1210136A1 (en) 2012-11-01 2015-11-02 Ingenol-derived compounds that can be used for treating cancer

Country Status (17)

Country Link
US (2) US20150315124A1 (xx)
EP (1) EP2915800B1 (xx)
JP (1) JP2016502509A (xx)
KR (1) KR20150073997A (xx)
CN (1) CN104755455B (xx)
AU (1) AU2013337538B2 (xx)
BR (1) BR102012028120B8 (xx)
CA (1) CA2889944C (xx)
ES (1) ES2668921T3 (xx)
HK (1) HK1210136A1 (xx)
IL (1) IL238043A (xx)
MX (1) MX2015005525A (xx)
NZ (1) NZ707636A (xx)
PT (1) PT2915800T (xx)
RU (1) RU2662712C2 (xx)
WO (1) WO2014066967A1 (xx)
ZA (1) ZA201503005B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016191837A1 (pt) * 2015-06-03 2016-12-08 Amazônia Fitomedicamentos Ltda. Método de preparação de ingenol-3-hexanoato, método de preparação de 3-etinil-3-hidroxi-4.7.7-trimetilbiciclo[4.1.0]heptano-2-carbaldeído e método de preparação do composto 2,2-dimetil-4-etinil-5-trifenilfosforanilideno-1,3-dioxano
WO2016191836A1 (pt) * 2015-06-03 2016-12-08 Amazônia Fitomedicamentos Ltda. Método de preparação de ingenol-3-dodecanoato, método de preparação de 3-etinil-3-hidroxi-4.7.7-trimetilbiciclo[4.1.0]heptano-2-carbaldeído e método de preparação de 2,2-dimetil-4-etinil-5-trifenilfosforanilideno-1,3-dioxano
WO2017089300A1 (en) * 2015-11-27 2017-06-01 Leo Laboratories Limited 3-alkylamido-3-deoxy-ingenols
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
US11715111B2 (en) * 2018-09-25 2023-08-01 Capital One Services, Llc Machine learning-driven servicing interface

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08245505A (ja) * 1994-09-09 1996-09-24 Tosoh Corp ジテルペン誘導体、その製造法及びそれを有効成分として含有する抗腫瘍剤
WO2006007676A1 (en) * 2004-07-21 2006-01-26 Amazônia Fitomedicamentos Ltda. Combination of active fractions from the plants euphorbia tirucalli l and ficos carica l. and method of treating cancer and aids
WO2006116897A1 (fr) * 2005-04-30 2006-11-09 Nihon University Diterpenes provenant de euphorbia kansui et leur utilisation
CN101257912A (zh) * 2005-06-28 2008-09-03 阿马佐尼亚菲托药品有限公司 大戟科植物乳汁的极性溶剂提取物的活性级份
US20090142421A1 (en) * 2005-06-28 2009-06-04 Amazonia Fitomedicamentos Ltda. Active fraction of a polar solvent extract from the latex of euphorbiaceae plants
US9388124B2 (en) * 2010-12-22 2016-07-12 Leo Laboratories Limited Ingenol-3-acylates I
NZ612446A (en) * 2010-12-22 2015-09-25 Leo Lab Ltd Ingenol-3-acylates iii and ingenol-3-carbamates
IN2014MN01911A (xx) * 2012-03-02 2015-07-10 Amazônia Fitomedicamentos Ltda

Also Published As

Publication number Publication date
CN104755455A (zh) 2015-07-01
CA2889944A1 (en) 2014-05-08
BR102012028120B1 (pt) 2021-03-09
KR20150073997A (ko) 2015-07-01
PT2915800T (pt) 2018-05-09
ES2668921T3 (es) 2018-05-23
BR102012028120B8 (pt) 2022-08-02
RU2015114967A (ru) 2016-12-20
US9713601B2 (en) 2017-07-25
WO2014066967A1 (pt) 2014-05-08
US20160287544A1 (en) 2016-10-06
BR102012028120A2 (pt) 2014-12-02
EP2915800A1 (en) 2015-09-09
EP2915800A4 (en) 2016-04-27
CN104755455B (zh) 2018-02-23
NZ707636A (en) 2019-01-25
AU2013337538B2 (en) 2018-03-15
CA2889944C (en) 2018-09-04
US20150315124A1 (en) 2015-11-05
JP2016502509A (ja) 2016-01-28
IL238043A (en) 2017-11-30
RU2662712C2 (ru) 2018-07-27
EP2915800B1 (en) 2018-02-28
AU2013337538A1 (en) 2015-05-21
MX2015005525A (es) 2015-07-21
ZA201503005B (en) 2017-08-30

Similar Documents

Publication Publication Date Title
IL289300A (en) Combined treatment for cancer
HK1209798A1 (en) Compositions and methods for treating cancer
EP2836482A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
EP2890720A4 (en) COMPOSITIONS AND METHODS OF TREATING CANCER
HK1220155A1 (zh) 治療癌症的方法
IL244353A0 (en) Compounds and use for cancer treatment
HK1210049A1 (en) Combination therapies for treating cancer
HRP20182041T1 (hr) Pripravci oksprenolola za liječenje raka
HK1210136A1 (en) Ingenol-derived compounds that can be used for treating cancer
HK1216854A1 (zh) 用於治療癌症的組合物和方法
EP2823825A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
EP2886122A4 (en) AGENT FOR THE TREATMENT OF CANCER
PL3071192T3 (pl) Związek kurkufenol do zastosowania w leczeniu nowotworu
PL3016682T3 (pl) Sposoby leczenia nowotworu
ZA201406172B (en) Compounds and methods for treating leukemia
EP2908813A4 (en) COMPOUNDS FOR TREATING RAC-GTPASE MEDIA DISORDER
PL2855475T3 (pl) Alfa-karboliny do leczenia nowotworu
HK1209040A1 (en) Methods for treating vestibulotoxicity
ZA201504169B (en) Anti-adam28 antibody for treating cancer
EP2841102A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2822593A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221103